Benjamin F. Edwards & Company, Inc. Dr Reddys Laboratories LTD Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 67 shares of RDY stock, worth $1,064. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67
Previous 70
4.29%
Holding current value
$1,064
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$170 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$146 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$144 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$139 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$98.5 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.64B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...